To give you context on how rid

2024-05-30

To give you context on how ridiculously costly some drugs are - $Novartis AG(NVS)$ Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status.

Unlike these unethical big pharmas, $Novo-Nordisk A/S(NVO)$ aims to provide more affordable healthcare through advancements in R&D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2024). This shows how committed Novo Nordisk is, in improving the health standards of society, globally.

Modified in.2024-05-30

LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?

Eli Lilly expects fiscal year revenue to be between $45.4 billion and $46.6 billion, up from the previous forecast of $42.4 billion to $43.6 billion. Eli Lilly's stock surged 10% in pre-market trading. Novo Nordisk (NVO) stock tumbled Wednesday after the Danish drugmaker reported a rare sales miss. ------------ Which weight loss drug company is a better buy?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

icycrystal
2024-05-30
icycrystal
thanks for sharing
- SPACE ROCKET:
  Awwwww! Thanks for stopping by! 😍🥰✨️

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":311294838059160,"tweetId":"311294838059160","gmtCreate":1717005368306,"gmtModify":1717005700506,"gmtUserModify":1717005696435,"author":{"id":4093561479903300,"idStr":"4093561479903300","authorId":4093561479903300,"authorIdStr":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/5f9c495dd9f776573648d60f1476fdab","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.28","exceedPercentage":"93.50%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":2815,"starInvestorFlag":true,"fullDisclosureFlag":false,"starInvestorFollowerNum":2133,"starInvestorOrderShareNum":605,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":318.54,"showRor":true,"investmentPhilosophy":"Take profits when they are due, cut losses when necessary, do not FOMO and catch falling knives 🙌🫶","winRationPercentage":56.40031,"tradeVolumeEst":0},"themes":[{"themeId":"3ba18faeb8364f42b810a81bee429b4d","categoryId":"7a15628ce2174325bddc6229505e0d70","name":"LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":3ba18faeb8364f42b810a81bee429b4d}&rnconfig={\"headerBarHidden\": true}","description":"Eli Lilly expects fiscal year revenue to be between $45.4 billion and $46.6 billion, up from the previous forecast of $42.4 billion to $43.6 billion. Eli Lilly's stock surged 10% in pre-market trading.\nNovo Nordisk (NVO) stock tumbled Wednesday after the Danish drugmaker reported a rare sales miss.\n------------\nWhich weight loss drug company is a better buy?","image":"https://community-static.tradeup.com/news/96ede51e656d3728375f75b1fee3f8e4"}],"images":[],"coverImages":[],"html":"<html><head></head><body>To give you context on how ridiculously costly some drugs are -&nbsp;<a href=\"https://ttm.financial/S/NVS\">$Novartis AG(NVS)$ </a> Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status.\n \nUnlike these unethical big pharmas,&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; aims to provide more affordable healthcare through advancements in R&amp;D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2024). This shows how committed Novo Nordisk is, in improving the health standards of society, globally.</body></html>","htmlText":"<html><head></head><body>To give you context on how ridiculously costly some drugs are -&nbsp;<a href=\"https://ttm.financial/S/NVS\">$Novartis AG(NVS)$ </a> Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status.\n \nUnlike these unethical big pharmas,&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; aims to provide more affordable healthcare through advancements in R&amp;D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2024). This shows how committed Novo Nordisk is, in improving the health standards of society, globally.</body></html>","text":"To give you context on how ridiculously costly some drugs are - $Novartis AG(NVS)$ Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status. Unlike these unethical big pharmas, $Novo-Nordisk A/S(NVO)$ aims to provide more affordable healthcare through advancements in R&D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2024). This shows how committed Novo Nordisk is, in improving the health standards of society, globally.","highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/311294838059160","repostId":0,"isVote":1,"tweetType":1,"viewCount":1130,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO","NVS"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":670,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":311297429884952,"commentId":"311297429884952","gmtCreate":1717005953512,"gmtModify":1717005956944,"authorId":4132300740238052,"author":{"id":4132300740238052,"idStr":"4132300740238052","authorId":4132300740238052,"name":"icycrystal","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":311294838059160,"objectIdStr":"311294838059160","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"thanks for sharing","text":"thanks for sharing","html":"thanks for sharing","likeSize":1,"commentSize":1,"subComments":[{"id":311300901236888,"commentId":"311300901236888","gmtCreate":1717006848585,"gmtModify":1717006853651,"authorId":4093561479903300,"author":{"id":4093561479903300,"idStr":"4093561479903300","authorId":4093561479903300,"name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/5f9c495dd9f776573648d60f1476fdab","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.28","exceedPercentage":"93.50%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":12,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":311294838059160,"objectIdStr":"311294838059160","type":1,"supId":311297429884952,"supIdStr":"311297429884952","prevId":0,"prevIdStr":"0","content":"Awwwww! Thanks for stopping by! 😍🥰✨️","text":"Awwwww! Thanks for stopping by! 😍🥰✨️","html":"Awwwww! Thanks for stopping by! 😍🥰✨️","disclaimerType":0}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/311294838059160"}